Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.06M | $ 224.67K | $ 359.87K | $ 407.05K | $ 445.06K |
Total Assets | $ 4.03M | $ 241.76K | $ 401.45K | $ 414.56K | $ 455.40K |
Total Debt | $ 231.88K | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ -829.65K | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 449.47K | $ 168.48K | $ 36.63K | $ 23.28K | $ 32.26K |
Stockholders Equity | $ 3.58M | $ 73.28K | $ 364.82K | $ 391.28K | $ 423.14K |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |